Tag Archives: CLF

Top 5 Blue Chip Stocks To Watch Right Now

The literary world is facing difficult questions about how it will move forward in the age of #MeToo after allegations of misconduct and verbal abuse were made against a Pulitzer Prize-winning author.

The accusations against Junot D铆az, who won the 2008 Pulitzer Prize for fiction for his novel “The Brief Wondrous Life of Oscar Wao,” were detailed during an exchange at a writers’ event and statements made on social media by multiple female authors, weeks after D铆az published a hailed essay about the repeated instances of sexual assault he endured as a child and the decades he’s spent dealing with the emotional aftermath.

CNN has been unable to verify the accusers’ claims, those in the literary community — from authors to booksellers — have spent the days since the allegations surfaced on Friday facing questions adjacent to those tackled by the entertainment industry when a string of sexual harassment and misconduct allegations were made against several prominent figures late last year, particularly whether or not to standby the accused.

Top 5 Blue Chip Stocks To Watch Right Now: Pacific Biosciences of California Inc.(PACB)

Pacific Biosciences of California, Inc., a development stage company, develops, manufactures, and markets an integrated platform for genetic analysis. The company engages in developing a technology platform that enables single molecule, real-time (SMRT) for the detection of biological processes. It primarily focuses on the deoxyribonucleic acid sequencing market. The company?s product includes the PacBio RS, a sequencing platform, which consists of an instrument platform that uses its proprietary consumables, such as SMRT Cells and reagent kits. The company?s customers include genome centers, genomics service providers, and agricultural companies, as well as clinical, government, and academic institutions. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.

Advisors’ Opinion:

  • [By Keith Speights]

    Illumina announced in November that it plans to acquire Pacific Biosciences of California (NASDAQ:PACB), frequently referred to as PacBio, for $1.2 billion. The move paves the way for Illumina to get its foot in the door in the long-read sequencing market.

  • [By Joseph Griffin]

    Pacific Biosciences of California (NASDAQ:PACB)’s share price traded up 2.3% during mid-day trading on Friday . The company traded as high as $5.82 and last traded at $5.42. 66,454 shares traded hands during trading, a decline of 95% from the average session volume of 1,471,044 shares. The stock had previously closed at $5.55.

  • [By Logan Wallace]

    Shares of Pacific Biosciences of California (NASDAQ:PACB) gapped up prior to trading on Thursday . The stock had previously closed at $4.99, but opened at $4.87. Pacific Biosciences of California shares last traded at $5.16, with a volume of 170693 shares traded.

Top 5 Blue Chip Stocks To Watch Right Now: Bio-Rad Laboratories, Inc.(BIO.B)

Bio-Rad Laboratories, Inc. (Bio-Rad), incorporated on March 10, 1975, is a manufacturer and distributor of life science research and clinical diagnostics products. The Company manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics. The Company’s Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Company’s Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. Bio-Rad sells over 8,000 products and services to a client base consisting of scientific research, healthcare, education and government customers around the world.

Life Science

The Company’s Life Science segment markets and develops, manufactures and markets a range of over 5,000 reagents, apparatus and laboratory instruments that serve a global customer base. Its products are used in established research techniques, biopharmaceutical production processes and food testing regimes. These techniques are used to separate, purify and identify biological materials, such as proteins, nucleic acids and bacteria within a laboratory or production setting. The Company focuses on selected segments of the life sciences market in proteomics (the study of proteins), genomics (the study of genes), biopharmaceutical production, cell biology and food safety. Its life science customers include universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers and food testing laboratories.

Clinical Diagnostics

The Company’s Clinical Diagnostic! s segment offers products that serve clinical laboratories in the global diagnostics market. Its products address the in vitro diagnostics (IVD) test market. The Company supplies over 3,000 different products that cover approximately 300 clinical diagnostic tests to the IVD test market. IVD tests are conducted outside the human body and are used to identify and measure substances in a patient’s tissue, blood or urine. The Company’s products consist of reagents, instruments and software, typically provided to its customers as an integrated package to allow them to generate reproducible test results. Its principal clinical diagnostic customers include hospital laboratories, reference laboratories, transfusion laboratories and physician office laboratories.

The Company competes with GE Biosciences, Merck Millipore, Thermo Fisher Scientific, Roche, Abbott Laboratories, Siemens, Danaher, Becton Dickinson, bioMerieux, Ortho Clinical Diagnostics, Tosoh, Immucor and DiaSorin.

Advisors’ Opinion:

  • [By Joseph Griffin]

    Bio-Rad Laboratories (NYSE:BIO.B) and Quanterix (NASDAQ:QTRX) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

Top 5 Blue Chip Stocks To Watch Right Now: Cliffs Natural Resources Inc.(CLF)

Cliffs Natural Resources Inc., a mining and natural resources company, produces iron ore pellets, lump and fines iron ore, and metallurgical coal products. The company operates six iron ore mines in Michigan, Minnesota, and eastern Canada; two iron ore mining complexes in Western Australia; five metallurgical coal mines located in West Virginia and Alabama; and one thermal coal mine located in West Virginia. It also owns a 45% economic interest in a coking and thermal coal mine located in Queensland, Australia; and a 30% interest in Amapa, a Brazilian iron ore project in Latin America, as well as chromite properties in Ontario, Canada. The company, formerly known as Cleveland-Cliffs Inc, was founded in 1847 and is headquartered in Cleveland, Ohio.

Advisors’ Opinion:

  • [By Tyler Crowe, Sean Williams, and Brian Stoffel]

    So we asked three Motley Fool contributors to each highlight a stock they see as a great value investment today. Here’s why they picked Walmart (NYSE:WMT), Bank of America (NYSE:BAC), and Cleveland-Cliffs (NYSE:CLF).

  • [By Shane Hupp]

    Shares of Cleveland-Cliffs Inc (NYSE:CLF) have been given an average recommendation of “Hold” by the fifteen analysts that are presently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $11.80.

  • [By John Bromels, Rich Smith, and Tyler Crowe]

    We asked three of our Motley Fool contributors to pick out a mining stock they think is poised to outperform, and they came back with iron minerCleveland-Cliffs(NYSE:CLF), precious metals streaming companyWheaton Precious Metals(NYSE:WPM), and Warren Buffett’sBerkshire Hathaway(NYSE:BRK-A)(NYSE:BRK-B). Yes, you read that right: Berkshire Hathaway. Here’s why they think these mining stocks might be right for your portfolio.

  • [By Lee Jackson]

    Jefferies likes this top mining play. Cleveland-Cliffs Inc. (NYSE: CLF) is a mining and natural resources company. It is a supplier of iron ore pellets to the North American steel industry from its mines and pellet plants located in Michigan and Minnesota. The company’s segments include U.S. Iron Ore and Asia Pacific Iron Ore. Operations of the latter are located in Western Australia and consist of its Koolyanobbing operation.

Top 5 Blue Chip Stocks To Watch Right Now: Kaman Corporation(KAMN)

Kaman Corporation, headquartered in Bloomfield, Connecticut, was incorporated in 1945. We are a diversified company that conducts business in the aerospace and distribution markets. We report information for ourselves and our subsidiaries (collectively, “we,” “us,” “our,” and “the Company”) in two business segments, Distribution and Aerospace. A discussion of 2015 developments is included in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, in this Form 10-K.
Distribution Segment
The Distribution segment brings our commitment to technological leadership and value-added services to the distribution business. The Distribution segment is a leading power transmission, motion control, electrical and automation, and fluid power industrial distributor with operations throughout the United States.   Advisors’ Opinion:

  • [By Joseph Griffin]

    Laurion Capital Management LP purchased a new position in shares of Kaman Co. (NYSE:KAMN) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 17,114 shares of the industrial products company’s stock, valued at approximately $1,192,000. Laurion Capital Management LP owned about 0.06% of Kaman as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Kaman (KAMN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Kaman (KAMN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Kaman Aircraft (NYSE:KAMN) hit a new 52-week high and low on Wednesday . The stock traded as low as $67.95 and last traded at $68.00, with a volume of 2807 shares traded. The stock had previously closed at $67.07.

Top 5 Blue Chip Stocks To Watch Right Now: Sierra Bancorp(BSRR)

Sierra Bancorp, incorporated on November 16, 2000, is a bank holding company for Bank of the Sierra (the Bank). The Bank is a state-chartered bank, which offers a range of retail and commercial banking services. The Bank’s products and services are related to the business of lending money and accepting deposits. The Bank operates approximately 30 branch offices, an online branch, a real estate industries group, an agricultural credit division, a Small Business Administration (SBA) lending unit and a loan production office. Its customers have access to electronic point-of-sale payment alternatives around the country through the Pulse Electronic Funds Transfer (EFT) network. Its Internet branch provides the ability to open deposit accounts online; an online banking option with bill-pay and mobile banking capabilities, including mobile check deposit; a customer service center that is accessible by toll-free telephone during business hours, and an automated telephone banking system. It offers a range of other banking products and services to complement and support its lending and deposit products, including remote deposit capture and automated payroll services for business customers. The Company’s other direct subsidiaries are Sierra Statutory Trust II and Sierra Capital Trust III, which are engaged in facilitating the issuance of capital trust pass-through securities.

Lending Activities

The Bank’s lending activities include real estate, commercial (including small business), agricultural and consumer loans. The bulk of its real estate loans are secured by commercial, professional office properties and agricultural properties, which are owner occupied. The Bank also offers a range of construction loans for residential and commercial development, permanent mortgage loans, land acquisition and development loans, and multifamily credit facilities. Secondary market services for residential mortgage loans are provided through the Bank’s affiliations with Freddie Mac, Fannie Mae and ce! rtain non-governmental institutions. The Bank’s total net loans are approximately $1,124.6 million.

Investment Activities

The Bank’s investments consist of debt and marketable equity securities (together, the investment portfolio), investments in the time deposits of other banks, surplus interest-earning balances in its Federal Reserve Bank account and overnight fed funds sold. The Bank’s securities are all marketable and are classified as available for sale, which include the United States Government agencies, mortgage-backed securities, state and political subdivisions, and equity securities. The Bank’s aggregate investments are approximately $510 million.

Sources of Funds

The Bank offers a range of deposit products for individuals and businesses, including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts and sweep accounts. The Bank’s non-maturity deposits include demand deposit accounts and negotiable order of withdrawal (NOW) accounts. The Bank has approximately 101,200 deposit accounts totaling over $1,465 billion. The Bank’s non-deposit borrowings include fed funds purchased from correspondent banks, borrowings from the Federal Home Loan Bank (FHLB), advances from the Federal Reserve Bank, securities sold under agreement to repurchase and junior subordinated debentures. The Bank uses short-term FHLB advances and fed funds purchased on uncommitted lines to support liquidity needs created by seasonal deposit flows and for other short-term purposes.

Advisors’ Opinion:

  • [By Shane Hupp]

    Sierra Bancorp (NASDAQ:BSRR) was downgraded by BidaskClub from a “hold” rating to a “sell” rating in a report released on Friday.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Sierra Bancorp (BSRR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Sierra Bancorp (NASDAQ:BSRR) and ServisFirst Bancshares (NASDAQ:SFBS) are both finance companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, risk, valuation, institutional ownership, analyst recommendations and earnings.

  • [By Shane Hupp]

    Sierra Bancorp (NASDAQ:BSRR) has been assigned a consensus recommendation of “Hold” from the seven analysts that are covering the stock, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $31.00.

Best Heal Care Stocks To Own For 2021

ValuEngine upgraded shares of Aethlon Medical (NASDAQ:AEMD) from a hold rating to a buy rating in a research report released on Monday.

Separately, HC Wainwright set a $3.00 price objective on Aethlon Medical and gave the company a buy rating in a research report on Monday.

Get Aethlon Medical alerts:

Aethlon Medical opened at $1.32 on Monday, MarketBeat reports. Aethlon Medical has a twelve month low of $0.79 and a twelve month high of $3.85. The company has a debt-to-equity ratio of 0.14, a current ratio of 15.38 and a quick ratio of 17.03. The company has a market cap of $23.62 million, a P/E ratio of -2.87 and a beta of 2.15.

Aethlon Medical (NASDAQ:AEMD) last posted its quarterly earnings data on Friday, June 8th. The medical equipment provider reported ($0.06) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.10) by $0.04. The company had revenue of $0.07 million for the quarter, compared to the consensus estimate of $0.09 million. equities research analysts forecast that Aethlon Medical will post -0.38 earnings per share for the current fiscal year.

Best Heal Care Stocks To Own For 2021: Landec Corporation(LNDC)

Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells polymer products for food and agricultural products, medical devices products, and licensed partner applications incorporating its patented polymer technologies. It has two polymer technology platforms that include Intelimer polymers, a proprietary class of crystalline, hydrophobic polymers, which respond to temperature changes in a controllable, predictable way; and Hyaluronan Biopolymer, a non-crystalline, hydrophilic polymer that exists naturally within the human body. The company?s Food Products Technology segment markets and packs produced and specialty packaged whole and fresh-cut vegetables utilizing the proprietary BreatheWay specialty packaging technology for the retail grocery, club store, and food services industry. This segment also sells BreatheWay packaging to partners for non-vegetable products. Its Food Export segment purchases and sells primarily whole commodity fruit and vegetable products to Asian markets. The company?s Hyaluronan-based Biomaterials segment sells products utilizing hyaluronan, a naturally occurring polysaccharide that is primarily distributed in the extracellar matrix of connective tissues in both animals and humans for medical use primarily in the ophthalmic, orthopedic, and veterinary markets. It also supplies hyaluronan to customers pursuing other medical applications, such as aesthetic surgery, medical device coatings, tissue engineering, and pharmaceuticals. Its Technology Licensing segment licenses Intellicoat, a proprietary seed coating technology to the farming industry; and Intelimer polymers for personal care products and other industrial products. The company sells its products in the United States, Canada, Taiwan, Belgium, Indonesia, China, and Japan. Landec Corporation was founded in 1986 and is based in Menlo Park, California.

Advisors’ Opinion:

  • [By Logan Wallace]

    Farmmi (NASDAQ:FAMI) and Landec (NASDAQ:LNDC) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, earnings and dividends.

  • [By Joseph Griffin]

    Farmmi (NASDAQ:FAMI) and Landec (NASDAQ:LNDC) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.

Best Heal Care Stocks To Own For 2021: Microvision Inc.(MVIS)

MicroVision, Inc. engages in the development of miniature laser display and imaging engines based upon its proprietary PicoP display engine technology. Its technology uses two dimensional micro-electrical mechanical systems, lasers, optics, and electronics to create a video or still image from a small form factor device. The company offers Pico projector displays intended to be used for users of mobile consumer devices, such as smartphones, media players, tablet PCs, and other consumer electronics products. Its products also comprise automotive head-up displays that project high-resolution images onto the windshield of an automobile providing the driver with information consisting of GPS mapping images, audio controls, and other automobile instrumentation information related to the car’s operation. In addition, the company offers near-eye wearable display platform to provide personal viewing of information from a mobile device through a wired or wireless connection. Furthe r, it offers ROV hand held bar code scanners, and bar code scanner enabled enterprise solutions through distributors and original equipment manufacturers, as well as directly to end users through its online store. The company serves customers operating in the consumer, defense, industrial, and medical markets. MicroVision, Inc. was founded in 1993 and is headquartered in Redmond, Washington.

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Microvision (MVIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Microvision (MVIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    IMPINJ (NASDAQ: PI) and MicroVision (NASDAQ:MVIS) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, risk, valuation, institutional ownership, analyst recommendations and earnings.

Best Heal Care Stocks To Own For 2021: Enphase Energy, Inc.(ENPH)

Enphase Energy, Inc., incorporated on March 20, 2006, is a provider of energy management solutions. The Company is engaged in designing, developing, manufacturing and selling microinverter systems for the solar photovoltaic (PV) industry. Its semiconductor-based microinverter system converts direct current (DC) electricity to alternating current (AC) electricity at the individual solar module level. The Company offers microinverter systems to the residential and commercial markets in the United States, Canada, the United Kingdom, France, the Benelux region, certain other European markets, Australia and New Zealand.

The Company’s microinverter system consists of three components: Enphase microinverters, an Envoy gateway and Enlighten cloud-based software. The Company’s Enphase microinverters provide power conversion at the individual solar module level by introducing a digital architecture that incorporates custom application specific integrated circuits (ASIC), specialized power electronics devices, and an embedded software subsystem. The Company’s Envoy bi-directional communications gateway is installed at the system location and serves as a hub providing collecting and sending data to Enlighten software, and receiving and distributing microinverter firmware or software updates, thus increasing system availability and providing ongoing utility compliance.

The Company’s Enlighten cloud-based software provides the capabilities to remotely monitor, manage, and maintain an individual system or a fleet of systems. The software collects and analyzes system performance information to enable owners and operators to realize the performance of their solar PV system. The two versions of the monitoring software include MyEnlighten, which is designed for the typical system owner, provides performance assurance, and Enlighten Manager, which is available for the solar professional, provides detailed diagnostic capabilities, as well as fleet management tools.

The Company compet! es with SMA Solar Technology AG, Fronius International GmbH, ABB Ltd. and SolarEdge Technologies, Inc.

Advisors’ Opinion:

  • [By ]

    Like GTLS, Enphase Energy (Nasdaq: ENPH) is trading near its 52-week high. Unlike GTLS, however, the stock of this energy converter and battery manufacturer, at its current levels of about $9 per share, still trades well below its five-year high of $16.98 set in 2014. 

  • [By Maxx Chatsko, Chris Neiger, and Neha Chamaria]

    With that in mind, we recently asked three contributors at The Motley Fool for one of their best stocks to buy and hold for the next two decades. Here’s why they chose Enphase Energy (NASDAQ:ENPH), Welltower (NYSE:WELL), and Microsoft (NASDAQ:MSFT).

Best Heal Care Stocks To Own For 2021: Cliffs Natural Resources Inc.(CLF)

Cliffs Natural Resources Inc., a mining and natural resources company, produces iron ore pellets, lump and fines iron ore, and metallurgical coal products. The company operates six iron ore mines in Michigan, Minnesota, and eastern Canada; two iron ore mining complexes in Western Australia; five metallurgical coal mines located in West Virginia and Alabama; and one thermal coal mine located in West Virginia. It also owns a 45% economic interest in a coking and thermal coal mine located in Queensland, Australia; and a 30% interest in Amapa, a Brazilian iron ore project in Latin America, as well as chromite properties in Ontario, Canada. The company, formerly known as Cleveland-Cliffs Inc, was founded in 1847 and is headquartered in Cleveland, Ohio.

Advisors’ Opinion:

  • [By Tyler Crowe, Sean Williams, and Brian Stoffel]

    So we asked three Motley Fool contributors to each highlight a stock they see as a great value investment today. Here’s why they picked Walmart (NYSE:WMT), Bank of America (NYSE:BAC), and Cleveland-Cliffs (NYSE:CLF). 

  • [By Shane Hupp]

    Shares of Cleveland-Cliffs Inc (NYSE:CLF) have been given an average recommendation of “Hold” by the fifteen analysts that are presently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $11.80.

Best Heal Care Stocks To Own For 2021: Fifth Street Asset Management Inc.(FSAM)

Fifth Street Asset Management Inc., incorporated on May 8, 2014, is an alternative asset manager with more than $6.3 billion of assets under management. The funds, managed by the Company, provide financing solutions to small and mid-sized companies across their capital structures, primarily in connection with investments by private equity sponsors. The Company’s credit solutions include one-stop financing, uni-tranche debt, senior secured debt, mezzanine debt, equity co-investments, healthcare asset-backed lending and venture debt financing. Its Business Development Companies (BDCs) are publicly-traded permanent capital vehicles that maintain a portfolio of a diverse range of companies in a tax-favored structure. These permanent capital vehicles are externally managed, closed-end, non-diversified investment companies. As of December 31, 2014, 90.5% of the Company’s assets under management reside in publicly-traded permanent capital vehicles, consisting of Fifth Street Finance Corp. (FSC) and Fifth Street Senior Floating Rate Corp. (FSFR). The Company conducts substantially all of its operations through its consolidated subsidiary, Fifth Street Management LLC (Fifth Street Management). The Company provides financing solutions across industry sectors, including healthcare, food and restaurants, manufacturing, software and technology, business services, energy, education, aerospace and defense, consumer products and marketing services.

Fifth Street Finance Corp.

FSC is a specialty finance company that lends to and invests in small and mid-sized companies, primarily in connection with investments by private equity sponsors. FSC’s investment objective is to maximize its portfolio’s total return by generating current income from its debt investments and capital appreciation from its equity investments. FSC is advised by Fifth Street Management.

Fifth Street Senior Floating Rate Corp.

FSFR is a specialty finance company whose investment objective is to maxi! mize the total return on its portfolio by generating current income from debt investments, while seeking to preserve capital. FSFR invests primarily in senior secured loans, including first lien, unitranche and second lien debt instruments, that pay interest at rates, which are determined periodically on the basis of a floating base lending rate, made to private middle market companies whose debt is rated below investment grade, which the Company refers to collectively as senior loans. FSFR may also invest in senior unsecured loans issued by private middle market companies and subordinated loans issued by private middle market companies and senior and subordinated loans issued by public companies. FSFR is advised by Fifth Street Management.

Senior Loan Funds

The investment objective of the Company’s funds, SLF I and SLF II, in its senior loan funds strategy is to generate leveraged returns by focusing on investing, directly or indirectly through subsidiaries, in senior, secured term loan debt (including broadly syndicated loans, first lien term loans, second lien loans and delayed draw term loans and revolving loans) of middle market companies. The portfolios of loan debt provide and are expected to continue to provide eligible collateral for warehouse financing and the Company expects that the portfolios of loan debt will provide eligible collateral for securitization financing that are employed by the senior loan funds to enhance the size of investment portfolios and magnify the returns generated from such portfolios.

Fifth Street Opportunities Fund

The investment objective of Fifth Street Opportunities Fund (FSOF) is to generate income and long-term capital appreciation. The Company intends to achieve the investment objective by primarily investing opportunistically in various credit-related instruments, including debt securities, instruments and obligations of the United States and non-United States government, corporate and other non-governmental ! entities ! and issuers and preferred and convertible preferred securities that include fixed-income features, and in publicly-traded equity and equity-linked securities, including the equity securities of BDCs managed by unaffiliated investment managers. FSOF’s general partner is FSCO GP LLC and its investment adviser is Fifth Street Management.

Advisors’ Opinion:

  • [By Logan Wallace]

    Fifth Street Asset Management (OTCMKTS:FSAM) and U.S. Global Investors (NASDAQ:GROW) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, institutional ownership, profitability, earnings and risk.

  • [By Logan Wallace]

    Fifth Street Asset Management (OTCMKTS: FSAM) and Triangle Capital (NYSE:TCAP) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, risk, profitability, analyst recommendations, valuation, earnings and dividends.

Best Heal Care Stocks To Own For 2021: BofI Holding Inc.(BOFI)

BofI Holding, Inc. operates as the holding company for BofI Federal Bank that provides various consumer and wholesale banking services primarily through the Internet in the United States. It accepts various deposit products, including demand deposit, savings, and certificates of deposit accounts. It also provides loan products, which consist of single family loans, home equity loans, multifamily loans, commercial real estate loans, recreational vehicle and automobile loans, and overdraft lines of credit In addition, the company offers online bill payment, interbank transfer, mobile banking, text message banking, ATM cards or VISA debit cards, and overdraft protection services. It serves approximately 36,000 retail deposit and loan customers across 50 states. BofI Holding, Inc. was incorporated in 1999 and is based in San Diego, California.

Advisors’ Opinion:

  • [By Stephan Byrd]

    BofI Holding, Inc. (NASDAQ:BOFI) – Analysts at DA Davidson boosted their Q1 2020 earnings per share (EPS) estimates for BofI in a research note issued on Monday, October 1st. DA Davidson analyst G. Tenner now forecasts that the financial services provider will post earnings of $0.82 per share for the quarter, up from their prior forecast of $0.76. DA Davidson also issued estimates for BofI’s Q2 2020 earnings at $0.85 EPS, Q3 2020 earnings at $1.24 EPS, Q4 2020 earnings at $0.83 EPS and FY2020 earnings at $3.73 EPS.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on BofI (BOFI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on BofI (BOFI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com